ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-22 |

Results: 22

ACTIVATION-ENERGY OF REPEATED CARBIDE PRE CIPITATION PROCESSES IN STEELS

Authors: HILDEBRAND H HEINZEL G HEGER D

Citation: H. Hildebrand et al., ACTIVATION-ENERGY OF REPEATED CARBIDE PRE CIPITATION PROCESSES IN STEELS, Materialwissenschaft und Werkstofftechnik, 29(1), 1998, pp. 16-22

PHARMACOKINETICS OF MELOXICAM IN ANIMALS AND THE RELEVANCE TO HUMANS

Authors: BUSCH U SCHMID J HEINZEL G SCHMAUS H BAIERL J HUBER C ROTH W

Citation: U. Busch et al., PHARMACOKINETICS OF MELOXICAM IN ANIMALS AND THE RELEVANCE TO HUMANS, Drug metabolism and disposition, 26(6), 1998, pp. 576-584

CHARACTERIZATION OF DUALPHASE DISPERSION MIXED MICROSTRUCTURE IN A FE-NB-C ALLOY/

Authors: HILDEBRAND H HEINZEL G SCHREIBER G

Citation: H. Hildebrand et al., CHARACTERIZATION OF DUALPHASE DISPERSION MIXED MICROSTRUCTURE IN A FE-NB-C ALLOY/, Praktische Metallographie, 35(5), 1998, pp. 255-266

PK PD SIMULATIONS AS A TOOL FOR RATIONAL DESIGN OF CLINICAL DOSAGE REGIMENS - AN EXAMPLE WITH FRADAFIBAN/

Authors: BRICKL R HEINZEL G WEISENBERGER H SCHUBERT H RUTSCH W ROTH W

Citation: R. Brickl et al., PK PD SIMULATIONS AS A TOOL FOR RATIONAL DESIGN OF CLINICAL DOSAGE REGIMENS - AN EXAMPLE WITH FRADAFIBAN/, International journal of clinical pharmacology and therapeutics, 35(10), 1997, pp. 475-480

COMPARATIVE CARDIAC TOXICITY OF THE IV ADMINISTERED BENZIMIDAZOLE PYRIDAZINON DERIVATIVE PIMOBENDAN AND ITS ENANTIOMERS IN FEMALE BEAGLE DOGS

Authors: SCHNEIDER P GUTTNER J ECKENFELS A HEINZEL G VONNICOLAI H TRIEB G LEHMANN H

Citation: P. Schneider et al., COMPARATIVE CARDIAC TOXICITY OF THE IV ADMINISTERED BENZIMIDAZOLE PYRIDAZINON DERIVATIVE PIMOBENDAN AND ITS ENANTIOMERS IN FEMALE BEAGLE DOGS, Experimental and toxicologic pathology, 49(3-4), 1997, pp. 217-224

POWER RECYCLING IN THE GARCHING 30 M PROTOTYPE INTERFEROMETER FOR GRAVITATIONAL-WAVE DETECTION

Authors: SCHNIER D MIZUNO J HEINZEL G LUCK H RUDIGER A SCHILLING R SCHREMPEL M WINKLER W DANZMANN K

Citation: D. Schnier et al., POWER RECYCLING IN THE GARCHING 30 M PROTOTYPE INTERFEROMETER FOR GRAVITATIONAL-WAVE DETECTION, Physics letters. A, 225(4-6), 1997, pp. 210-216

MELOXICAM PHARMACOKINETICS IN RENAL IMPAIRMENT

Authors: BOULTONJONES JM GEDDES CG HEINZEL G TURCK D NEHMIZ G BEVIS PJR

Citation: Jm. Boultonjones et al., MELOXICAM PHARMACOKINETICS IN RENAL IMPAIRMENT, British journal of clinical pharmacology, 43(1), 1997, pp. 35-40

LACK OF INTERACTION BETWEEN MELOXICAM AND WARFARIN IN HEALTHY-VOLUNTEERS

Authors: TURCK D SU CAPF HEINZEL G BUSCH U BLUHMKI E HOFFMANN J

Citation: D. Turck et al., LACK OF INTERACTION BETWEEN MELOXICAM AND WARFARIN IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 51(5), 1997, pp. 421-425

DURATION OF ACTION AND PHARMACOKINETICS OF THE ORAL ANTIDIABETIC DRUGGLIQUIDONE IN PATIENTS WITH NON-INSULIN-DEPENDENT (TYPE-2) DIABETES-MELLITUS

Authors: VONNICOLAI H BRICKL R ESCHEY H GREISCHEL A HEINZEL G KONIG E LIMMER J RUPPRECHT E

Citation: H. Vonnicolai et al., DURATION OF ACTION AND PHARMACOKINETICS OF THE ORAL ANTIDIABETIC DRUGGLIQUIDONE IN PATIENTS WITH NON-INSULIN-DEPENDENT (TYPE-2) DIABETES-MELLITUS, Arzneimittel-Forschung, 47(3), 1997, pp. 247-252

CLINICAL PHARMACOKINETICS OF MELOXICAM

Authors: TURCK D BUSCH U HEINZEL G NARJES H

Citation: D. Turck et al., CLINICAL PHARMACOKINETICS OF MELOXICAM, Arzneimittel-Forschung, 47(3), 1997, pp. 253-258

PHARMACOKINETICS OF MELOXICAM IN PATIENTS WITH HEPATIC CIRRHOSIS IN COMPARISON WITH HEALTHY-VOLUNTEERS

Authors: BUSCH U HEINZEL G NARJES H NEHMIZ G TURCK D KRIMMER J ROSCH W

Citation: U. Busch et al., PHARMACOKINETICS OF MELOXICAM IN PATIENTS WITH HEPATIC CIRRHOSIS IN COMPARISON WITH HEALTHY-VOLUNTEERS, Clinical drug investigation, 11(2), 1996, pp. 97-107

CARBIDE PARTICLE FORMATION AND DIFFUSION IN STEELS

Authors: HILDEBRAND H HEGER D HEINZEL G

Citation: H. Hildebrand et al., CARBIDE PARTICLE FORMATION AND DIFFUSION IN STEELS, Materialwissenschaft und Werkstofftechnik, 27(8), 1996, pp. 401-407

AN EXPERIMENTAL DEMONSTRATION OF RESONANT SIDE-BAND EXTRACTION FOR LASER-INTERFEROMETRIC GRAVITATIONAL-WAVE DETECTORS

Authors: HEINZEL G MIZUNO J SCHILLING R WINKLER W RUDIGER A DANZMANN K

Citation: G. Heinzel et al., AN EXPERIMENTAL DEMONSTRATION OF RESONANT SIDE-BAND EXTRACTION FOR LASER-INTERFEROMETRIC GRAVITATIONAL-WAVE DETECTORS, Physics letters. A, 217(6), 1996, pp. 305-314

PHARMACOKINETICS AND TOLERABILITY OF MELOXICAM AFTER IM ADMINISTRATION

Authors: NARJES N TURCK D BUSCH U HEINZEL G NEHMIZ G

Citation: N. Narjes et al., PHARMACOKINETICS AND TOLERABILITY OF MELOXICAM AFTER IM ADMINISTRATION, British journal of clinical pharmacology, 41(2), 1996, pp. 135-139

INTERACTION OF MELOXICAM WITH CIMETIDINE, MAALOX, OR ASPIRIN

Authors: BUSCH U HEINZEL G NARJES H NEHMIZ G

Citation: U. Busch et al., INTERACTION OF MELOXICAM WITH CIMETIDINE, MAALOX, OR ASPIRIN, Journal of clinical pharmacology, 36(1), 1996, pp. 79-84

PHARMACOKINETICS OF MELOXICAM IN PATIENTS WITH END-STAGE RENAL-FAILURE ON HEMODIALYSIS - A COMPARISON WITH HEALTHY-VOLUNTEERS

Authors: TURCK D SCHWARZ A HOFFLER D NARJES HH NEHMIZ G HEINZEL G

Citation: D. Turck et al., PHARMACOKINETICS OF MELOXICAM IN PATIENTS WITH END-STAGE RENAL-FAILURE ON HEMODIALYSIS - A COMPARISON WITH HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 309-313

PK PD STUDY OF BIBR 363 CL(2), A LONG-LASTING ANGIOTENSIN-II (A-II) ANTAGONIST - PREDICTION OF OPTIMAL DOSES FOR MULTIPLE DOSING FROM SINGLE-DOSE RESULTS/

Authors: HECHT A HEINZEL G STANGIER J DUONG DN SU CAPF

Citation: A. Hecht et al., PK PD STUDY OF BIBR 363 CL(2), A LONG-LASTING ANGIOTENSIN-II (A-II) ANTAGONIST - PREDICTION OF OPTIMAL DOSES FOR MULTIPLE DOSING FROM SINGLE-DOSE RESULTS/, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 18-18

EFFECT OF FOOD ON THE PHARMACOKINETICS OF MELOXICAM AFTER ORAL-ADMINISTRATION

Authors: TURCK D BUSCH U HEINZEL G NARJES H NEHMIZ G

Citation: D. Turck et al., EFFECT OF FOOD ON THE PHARMACOKINETICS OF MELOXICAM AFTER ORAL-ADMINISTRATION, Clinical drug investigation, 9(5), 1995, pp. 270-276

PHARMACOKINETIC-PHARMACODYNAMIC AND METABOLITE MODELING WITH TOPFIT

Authors: TANSWELL P HEINZEL G WEISENBERGER H ROTH W

Citation: P. Tanswell et al., PHARMACOKINETIC-PHARMACODYNAMIC AND METABOLITE MODELING WITH TOPFIT, International journal of clinical pharmacology and therapeutics, 33(10), 1995, pp. 550-554

THE EFFECT OF MELOXICAM ON THE PHARMACOKINETICS OF BETA-ACETYL-DIGOXIN

Authors: DEGNER FL HEINZEL G NARJES H TURCK D

Citation: Fl. Degner et al., THE EFFECT OF MELOXICAM ON THE PHARMACOKINETICS OF BETA-ACETYL-DIGOXIN, British journal of clinical pharmacology, 40(5), 1995, pp. 486-488

MELOXICAM - PHARMACOKINETICS AND METABOLIC PATTERN AFTER INTRAVENOUS-INFUSION AND ORAL-ADMINISTRATION TO HEALTHY-SUBJECTS

Authors: SCHMID J BUSCH U HEINZEL G BOZLER G KASCHKE S KUMMER M

Citation: J. Schmid et al., MELOXICAM - PHARMACOKINETICS AND METABOLIC PATTERN AFTER INTRAVENOUS-INFUSION AND ORAL-ADMINISTRATION TO HEALTHY-SUBJECTS, Drug metabolism and disposition, 23(11), 1995, pp. 1206-1213

THE EFFECT OF CHOLESTYRAMINE ON THE PHARMACOKINETICS OF MELOXICAM, A NEW NONSTEROIDAL ANTIINFLAMMATORY DRUG (NSAID), IN MAN

Authors: BUSCH U HEINZEL G NARJES H

Citation: U. Busch et al., THE EFFECT OF CHOLESTYRAMINE ON THE PHARMACOKINETICS OF MELOXICAM, A NEW NONSTEROIDAL ANTIINFLAMMATORY DRUG (NSAID), IN MAN, European Journal of Clinical Pharmacology, 48(3-4), 1995, pp. 269-272

Risultati: 1-22 |